Loading chat...
OK HB1419
Bill
Status
5/24/2013
Primary Sponsor
Richard Morrissette
Click for details
AI Summary
-
Oklahoma State Bureau of Narcotics and Dangerous Drugs Control Director must send written or electronic notification to practitioners when a patient is identified as engaging in fraudulent efforts to obtain multiple prescriptions for controlled dangerous substances
-
Authorizes the Bureau to enter into agreements and contracts with vendors to facilitate electronic transmission of prescription monitoring data to registrants and authorized persons
-
Amends 63 O.S. 2011, Sections 2-106 and 2-309F relating to the Anti-Drug Diversion Act and Director's powers and duties
-
Effective date: November 1, 2013
Legislative Description
Public health and safety; directing written notification be sent to practitioners under certain circumstances; agreements and contracts regarding data in central repository; effective date.
Health Care
Last Action
Approved by Governor 05/29/2013
5/24/2013